Again, whilst all somewhat valid - the market was pricing this as a goldilocks style execution by BB.
Reality, it’s got a diminishing cash balance, operates in a highly inflationary environment & is relying on a bullish NPV to justify the current market cap.
Pull back perfectly in order. Probably needs to shed another 10% - 15% to be approaching something more reasonable from a valuation perspective.
- Forums
- ASX - By Stock
- DVP
- Ann: 31 December Quarterly Cash Flow Report
Ann: 31 December Quarterly Cash Flow Report, page-17
Featured News
Add DVP (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.94 |
Change
-0.040(2.03%) |
Mkt cap ! $525.2M |
Open | High | Low | Value | Volume |
$1.99 | $2.03 | $1.94 | $16.01M | 8.235M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 19858 | $1.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.98 | 5829 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 19858 | 1.930 |
1 | 4858 | 1.925 |
3 | 20326 | 1.920 |
2 | 10079 | 1.915 |
3 | 104858 | 1.910 |
Price($) | Vol. | No. |
---|---|---|
1.980 | 5829 | 1 |
1.985 | 5829 | 1 |
1.990 | 5829 | 1 |
1.995 | 5829 | 1 |
2.000 | 15481 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
DVP (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online